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Background: Glaucoma is a leading cause of blindness. Early detection is advocated but there is insufficient
evidence from randomized controlled trials (RCTs) to inform health policy on population screening. Primarily, there
is no agreed screening intervention. For a screening programme, agreement is required on the screening tests to
be used, either individually or in combination, the person to deliver the test and the location where testing should
take place. This study aimed to use ophthalmologists (who were experienced glaucoma subspecialists),
optometrists, ophthalmic nurses and patients to develop a reduced set of potential screening tests and testing
arrangements that could then be explored in depth in a further study of their feasibility for evaluation in a
glaucoma screening RCT.
Methods: A two-round Delphi survey involving 38 participants was conducted. Materials were developed from a
prior evidence synthesis. For round one, after some initial priming questions in four domains, specialists were asked
to nominate three screening interventions, the intervention being a combination of the four domains; target
population, (age and higher risk groups), site, screening test and test operator (provider). More than 250 screening
interventions were identified. For round two, responses were condensed into 72 interventions and each was rated
by participants on a 0-10 scale in terms of feasibility.
Results: Using a cut-off of a median rating of feasibility of ≥5.5 as evidence of agreement of intervention feasibility,
six interventions were identified from round 2. These were initiating screening at age 50, with a combination of
two or three screening tests (varying combinations of tonometry/measures of visual function/optic nerve damage)
organized in a community setting with an ophthalmic trained technical assistant delivering the tests. An alternative
intervention was a ‘glaucoma risk score’ ascertained by questionnaire. The advisory panel recommended that
further exploration of the feasibility of screening higher risk populations and detailed specification of the screening
tests was required.
Conclusions: With systematic use of expert opinions, a shortlist of potential screening interventions was identified.
Views of users, service providers and cost-effectiveness modeling are now required to identify a feasible
intervention to evaluate in a future glaucoma screening trial.* Correspondence: susan.campbell@uea.ac.uk
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Glaucoma is a chronic progressive eye disease and is the
leading cause of irreversible blindness worldwide [1].
Open Angle Glaucoma (OAG) is the most common
form of glaucoma [2]. OAG is asymptomatic until
advanced stages of the disease but if identified early,
treatment can be relatively effective at reducing the rate
of progression [3]. In the UK, glaucoma is detected by
opportunistic case finding usually bay an optometrist.
Tests for glaucoma involve assessment of structural
changes at the optic nerve head by fundoscopy or im-
aging, functional visual loss by visual field testing and
the level of intraocular pressure. Of an estimated half a
million people affected in the UK, estimates from popu-
lation based studies suggests that less than half have
been diagnosed [4]. A population screening programme
for OAG has been proposed as a policy to reduce the
burden of glaucoma; however, before a screening
programme is introduced robust evidence from high
quality randomized controlled trials (RCTs) is required
to demonstrate that any benefits of screening on redu-
cing sight loss outweigh any potential harms and that
this is cost effective [5].
The available literature on the clinical and cost-
effectiveness of screening for OAG was summarized in a
recent health technology assessment (HTA) [6,7]. No
RCTs of screening were identified [6]. Prior to the con-
duct of any large definitive screening trial, evidence is
required to develop the components of the screening
interventions to be tested. The HTA report identified
uncertainties regarding the clinical components of the
intervention namely: the selection of optimal screening
approaches (including the choice of screening tests);
how and where screening should be provided and which
healthcare professionals would administer the test;
whether the screening process should be limited to
individuals in the ‘at risk’ groups, (e.g. those with a
family history of glaucoma in a first degree relative or
those of black ethnicity) or to screening based on age
criteria alone.
Screening tests should be relatively simple, safe and
acceptable to the population being tested and sufficiently
sensitive and specific to distinguish those who do or do
not have the condition. Facilities should be in place for
those screening positive to have further testing to estab-
lish a diagnosis [5].
The process of intervention development requires that
the intervention is feasible for both evaluation in the
RCT and importantly for any future implementation in a
policy context. Thus, in addition to likely future effect-
iveness identified from evidence synthesis, selection of
the optimal glaucoma screening intervention rests on
the feasibility and in a service context and on economic
considerations.These criteria may be explored using a range of re-
search methods. The Delphi method provides opportun-
ity for experts to communicate their opinions and
knowledge about a complex problem in order to explore
options and potentially reach consensus even if they are
in geographically dispersed areas. It has application in
many fields such as healthcare, education and sociology
[8]. It can also help to remove the bias of face to face
consensus meetings where interaction can sometimes
lead to those with a stronger opinions dominating the
decision making process [9-11].
The process is repeated until a level of agreement is
reached [9]. This is achieved through a series of question-
naires (known as ‘rounds’) together with feedback about
questionnaire data from earlier rounds [12]. There are no
strict guidelines on the most appropriate number of rounds
as this is a function of the complexity of the issues to be
decided and the heterogeneity of the sample recruited. How-
ever, it generally ranges from two to four rounds [11-14].
We report a two round Delphi process with experts in
the area of glaucoma screening. The purpose of the Del-
phi was to reduce the many potential components of a
screening intervention, in terms of who to screen and
how in terms of optimal testing schedule, to a reduced
set of potential interventions that could be explored in
depth in a qualitative enquiry within a UK National
Health Service (NHS) context. The qualitative enquiry
has been reported elsewhere [15].
Methods
Taking evidence from a prior evidence synthesis [8] a
two-round Delphi process was conducted. Results were
then reported to the project advisory panel for discus-
sion and critique of the results. The results including
suggestions from the project advisory panel were taken
forward to the next stage of the research [15,16].
Group selection
We sampled purposively to include a range of relevant
health professional groups (ophthalmologists, optome-
trists and ophthalmic nurses) as well as patient represen-
tation in the UK and internationally [9]. Sampling was
weighted in favor of ophthalmologists from the UK (due
to their expert knowledge of the NHS system where the
proposed trial and future screening policy would be
implemented). Ophthalmologists were selected who
were subspecialists in glaucoma and had published in
the field (in order to examine the views of those treating
glaucoma, about the best screening strategies). Those
ophthalmologists selected as International experts were
members of the World Glaucoma Association consensus
panel for screening for glaucoma. Optometrists were
selected as they would have additional views particularly
on the administration of the tests, nurses who had
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sentatives of the International Glaucoma Association.
Measures and procedures
The first-round questionnaire was sent with a partici-
pant information sheet and an explanation of the attri-
butes of potential glaucoma screening tests to 38
potential participants. The screening tests chosen, and
the detail on each test, were based on evidence from a
systematic review, and from subsequent reports on
population based screening studies [4,6,7,17-24]. There
were three tests of visual function, three tests of optic
nerve damage and three alternative methods of measur-
ing intraocular pressure (tonometry). (For details of the
screening test attributes see Additional file 1).
The questionnaire consisted of four sections. First,
participants were invited to rate tests of visual function
and structural loss and intraocular pressure on a scale
between 0-4 with 4 indicating that the test was ‘very
suitable’ as part of an intervention to be evaluated in a
future RCT and 0 indicating that it was ‘not suitable’.
Second, to suggest one or more tests to be used to
screen for glaucoma; third to give their views on the tar-
get population, such as age, risk factor, whether screen-
ing should be based on age alone and whether screening
tests should vary according to the population being
screened; and fourth, to suggest the screening site and
operator, e.g. the home, mobile van or General Practi-
tioner and who should provide the test, e.g. a nurse,
ophthalmologist, optometrist, ophthalmic trained tech-
nical assistant, as well as the combinations of where the
screening should take place and by whom. These four
parts to the questionnaire were essentially to help focus
participants into, finally, listing their top three combina-
tions of screening interventions within each of the four
domains:, tests, population, provider and site, to be eval-
uated in the proposed RCT. Free text boxes were pro-
vided to allow participants to add additional comments.
Results from the first round questionnaire for each
section of testing strategy, target population, screening
site and operator were fed back to 31 (82%) of the 38
participants who completed round one and two partici-
pants who were unable to complete round one but could
take part in round two (Additional file 2, feedback to
participants). Then the second questionnaire presented
the combinations of screening interventions which each
participant had identified in the final part of the round
one questionnaire. As there were more than 250 combi-
nations we condensed responses into common themes.
For example for the location of the test, mobile van, the
General Practitioners’ surgery, or a retail setting were
represented as a community-based “visual screening
centre” (VSC). This condensing process resulted in a
questionnaire consisting of 72 combinations being sentto participants. Eight of these combinations were chosen
by more than one participant and were automatically
included in the second round (Table 1). An asterisk next
to the eight combinations on the second questionnaire
indicated that it had been chosen by more than one re-
spondent in round one.
Figure 1 displays an example test combination and
instructions that were given to participants for complet-
ing the questionnaire. The round two questionnaires
were sent to those who agreed to participate in this next
round, with the detailed report of round one, as well as
an explanation of the attributes of tests of visual func-
tion, the same as the round one material (Additional file 1).
The 72 testing combinations described in the feedback
portion of questionnaire specified the target population,
the site where the screening could take place, who would
conduct the screening and finally the tests which would
be carried out. Participants were asked to rate their prefer-
ences on a scale of 0 (the test should not be considered)
to 10 (should be considered) as the screening intervention
to be evaluated.
Data analysis
The first round percentage agreement is presented,
below, for each section of the questionnaire. For the sec-
ond round it was agreed a priori to include all combina-
tions with a median above 5 (on the 0 – 10 point scale).
Therefore for each of the 72 combinations, the median
of the participants’ scores was calculated and the combi-
nations with median scores of 5.5 and over were pre-
sented and discussed with the advisory panel before
being taken forward to the next phase of research [15].
The advisory panel of 12 people included ophthalmolo-
gists, optometrists, an ophthalmic nurse, a patient and a
patient organization representative.
This study was classified as a service evaluation and
did not require national research ethics committee
approval (as advised by the North of Scotland Ethics
Committee). We certify that all applicable institutional
and governmental regulations concerning the ethical use
of human volunteers were followed during this research.
Results
Round 1
Thirty-one of 38 (82%) questionnaires were returned in
round one. However, two who were unable to be involved
in the first round had indicated their willingness to be
involved in round 2. Therefore, the round 2 sample con-
sisted of 33 participants and 23 (70%) questionnaires
were returned. Respondents consisted of 15 ophthalmol-
ogists, 6 optometrists, 1 ophthalmic nurse and 1 service
user. The majority of respondents were from the UK due
to the sampling strategy but Europe, USA, Canada and
Australia were also represented.
Table 1 Combinations from round one suggested by more than one respondent
Population Site Provider Test
60 years vision screening centre technician* SAP
50 years hospital nurse GAT and fundoscopy
50 years vision screening centre technician* tonometry (Icare or tonopen or NCT) and FDT
50 years optometry practice optometrist GAT and fundoscopy
50 years optometry practice optometrist GAT and FDT
40 years for those with FH or of black ethnicity vision screening centre technician* SAP (non specified) repeat test required
40 years for those with FH or of black ethnicity vision screening centre optometrist or technician* GAT and angle assessment,
HRT and visual function test
40 years for those with FH or of black vision screening centre technician* FDT
* ophthalmic trained technical assistant FDT – Frequency doubling perimetry GAT - Goldmann applanation tonometry HRT-Heidelberg Retina Tomograph.
NCT – Non-contact tonometry.
SAP – Standard automated perimetry.
FH - First degree relative with glaucoma.
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file 2 Feedback to participants from the round one Delphi.
Twenty nine (93%) indicated that a test of visual func-
tion should be considered, 28 (90%) a test of structural
loss and 28 (90%) a measure of intraocular pressure.
However, there was wide variation in rating of which testPopulation Site Provide
* 50 years Community 
Optometric 
Practice
Technic
This example means that you rate this comb
would strongly consider this screening strate
* - indicates that this combination was sugg
the first round of questionnaires.
Please now rate the following combinations o
Should not be considered
0 5
Figure 1 Example combination and instructions on how participants
means that you rate this combination as an 8 on a scale of 0-10, and woul
* - indicates that this combination was suggested by more than one respo
following combinations on a scale from 0-10.in each of these categories was most suitable for use.
(See Additional file 2).
For the age when screening should start, one participant
(3%) would screen at 30 years of age for those of black
ethnicity. Nine (29%) would begin screening for those in
their 40s but the majority, 17 (55%) recommended 50s
with four (16%) recommending 60 years of age.r Test Preference 
Rating
ian FDT & HRT or GDX
8
ination as an 8 on a scale of 0-10, and 
gy in a RCT.
ested by more than one respondent in 
n a scale from 0-10.
Should be considered
10
were asked to complete the questionnaire (Round 2). This example
d strongly consider this screening strategy in a RCT.
ndent in the first round of questionnaires. Please now rate the
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to age and an additional risk factor, 12 (39%) would
screen on age alone with an additional risk factor and
five (16%) were unsure. Respondents who recom-
mended screening on age and another risk factor, 24
(77%) identified having a parent with OAG, 23 (74%) a
sibling with OAG, 22 (71%) people of black ethnic
group, as the important risk factors. When asked if the
screening tests would vary according to the population
screened only 8 (26%) respondents would vary their
choice of tests according to the population being
screened.
The majority indicated suitable (rated 3 and 4 on the
0-4 scale) sites to administer the tests were community
optometric practice (24, 78%), mobile van (14, 46%) or
general practice (13, 42%). Several novel sites were also
suggested, open access care centers for those not regis-
tered with a General Practitioner, shopping malls,
church or community centers. The top test operator
(rated 4, very suitable) was technician (15, 48%), com-
munity optometrist (12, 39%), specialist glaucoma
trained optometrist (12, 39%), nurse (8, 26%) and only
one (3%) rated self testing as very suitable.
Round 2
Based on the reported responses the participants were
then asked to rate the 72 combinations in terms of their
feasibility as screening interventions for evaluation in a fu-
ture screening trial. Figure 2 shows the median scores for
every screening strategy combination. The top six combi-
nations (median of 5.5 and over) are detailed in Table 2.
There was evidence of consensus for initiating screening
at age 50 and for screening taking place in a community
setting (either the optometrists or a community visualFigure 2 Distribution of median scores for every screening strategy cscreening centre (VSC), with ophthalmic trained technical
assistants delivering the screening tests which were all
rated individually as very suitable in round 1. Tailoring
screening to higher risk groups was not short-listed.
However, one combination did include a questionnaire to
identify at-risk groups.
The selected top combinations were a combination of
the individual preferences in round one for screening
starting at age 50, in a community setting, by a technician.
A wide range of tests for the screening intervention
were identified and round one had highlighted some
uncertainties around the tests from free text comments
(section “Quotes from the round one Delphi ques-
tionnaires showing reasons for lack of consensus
about tests”) which seems to be reflected in the differ-
ent tests chosen.
Choice of screening strategy
‘It is my belief that threshold field tests are
inappropriate for screening
(should be reserved for diagnosis) because they are
associated with considerable false positives (and
probably false negatives).’
‘Simple functional test should be used’
‘Any screening programme for glaucoma must include
a field test.’
‘Technicians are better at following protocols than
doctors’.
‘I rated certain combinations low because I don’t
believe the method has any value in any usage (i.e.
Icare tonometer).’
‘I am very uncertain about tonometry in screening-do
we want to detect ocular hypertension or glaucoma? If
we test for ocular hypertension we will generate hugeTop 6 
Combinations
ombination.
Table 2 Shortlisted interventions from round two
Population Site Provider Test Median
50 years Optometry Practice Technician*/Optometrist NCT, SAP (multiple stimuli) and HRT 6
50 years Optometry Practice Technician* Icare tonometry, FDT, and disc photography 6
50 years VSC Technician* Tonometry (Icare or tonopen or NCT) and FDT 6
50 years VSC Technician* GAT, SAP and disc photography 6
50 years + risk score VSC Technician* Tonometry and rapid reproducible imaging or visual function test 6
50 years VSC Technician* NCT and FDT and HRT or GDx 5.5
* ophthalmic trained technical assistant.
Risk score - based on self identified risk factors by questionnaire sent to the screening cohort - including family history, black ethnic group, myopia or no prior
visits to eye care services.
VSC – Vision Screening Centre.
FDT – Frequency doubling perimetry GAT - Goldmann applanation tonometry GDx - Scanning laser polarimetry.
HRT – Heidelberg retinal tomograph.
NCT – Non-contact tonometry.
SAP – Standard automated perimetry.
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have ocular hypertension (many of whom will have a
thick cornea). Though radical, I think we should
exclude intraocular pressure, on balance, since it is
such a poor test for glaucoma.’
‘The screening programme must be feasible in terms of
cost of equipment and paying for technicians, which
eliminates almost everything except Non Contact
Tonometry, and computer based solutions such as
Frequency Doubling Technology, Motion Detection
Technology and Oculo-Kinetic Perimetry.’
The advisory panel
These results were then presented to the advisory panel.
The panel agreed that the six short-listed interventions
would be combinations which would be worth taking
forward to explore in our interviews with providers in
the next part of the research [15,16]. It was noted that
many of the chosen tests were not screening tests but
diagnostic tests, in that the initial test for screening is
not supposed to give the definitive answer but to identify
those who are unlikely to have glaucoma and move
those with a positive result for further scrutiny and diag-
nosis [24]. The advisory panel recommended that during
the interviews a single technology based test ± tonome-
try as the screening intervention should also be
explored, with the battery of tests identified in round
two as the diagnostic strategy for people whose test re-
sult was positive on the initial screening.
The panel noted that the six combinations did not in-
clude a combination for identifying at risk groups, (those
with a family history of glaucoma in a first degree rela-
tive or those of black ethnicity), apart from a screening
questionnaire. It was recommended to explore how best
to target the higher risk groups in the coming interviews
highlighted above. The panel recommended that other
vulnerable groups at greater risk of going blind from late
detected glaucoma are those from low socio-economicgroups, low education groups and those who are house-
bound and known not to have easy access to eye care
services. A few members of the panel argued that the
greatest risk was linked to late or no contact with eye
care services and social deprivation rather than to black
ethnicity. For all members the main problem proposed
was identifying interventions that would encourage
those at risk to attend for screening. This would be
particularly difficult for at risk groups, such as Afro-
Caribbean groups, where the risk of open angle
glaucoma may be greater than for other African groups.
Most members felt it would be more acceptable and
feasible to identify the target population by age, geog-
raphy and social deprivation scores for example by post
code, electoral roll and General Practice records.
Discussion
The Delphi panel of experts identified six screening inter-
vention combinations to take forward to the next phase of
the research. All included starting screening at age 50 years
with one using an additional risk score to identify at risk
groups. Most identified the site as a community based
visual screening centre which included, general practice,
mobile van or retail outlet, with the other combinations
identifying community optometry. All combinations
included an ophthalmic trained technician as the test pro-
vider with one combination also including an optometrist.
Opinions about tests were less certain but most included
a measure of intra ocular pressure.
The response rate to our Delphi survey for both
rounds was high. Main studies detailing the method
argue that rigor can be maintained with a response rate
of 70% which we have reached [8,10]. Our panel was
made up of a range of experts in the field of ophthalmol-
ogy. Mainly UK based as this was related to provision
within the NHS. Our panel of international experts was
small and may not include the views of all with an inter-
est in glaucoma screening.
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odology for the selection of experts and there are varia-
tions in the guidance on the minimum or maximum
number of experts required [25]. What appears to be im-
portant is common sense, and practical logistics to gain
coverage of relevant expertise, not based on numbers but
on the quality of the group, to ensure specialist consider-
ation of a wide range of views [14]. Using the purposive
sampling approach helped to achieve agreement in most
of the components and the range of tests reflects the dif-
ferences in clinical opinion which does require further ex-
ploration. Having a further advisory panel which included
a range of experts and a service user helped to provide an-
other clinical view as well as explore other areas of im-
portance (such as at risk groups) and the possibilities for
further study. However, we do acknowledge the potential
for bias in the experts and group selected.
Although a Delphi process removes some of the pro-
blems of interaction it also can remove some of the ben-
efits of an exchange of information [25]. Therefore,
reporting the results to the advisory panel, the further
discussion helped to confirm that, given the number of
tests selected, some participants appeared to be identify-
ing a diagnostic strategy rather than a screening strategy.
There was also recognition that high-risk groups had
not been shortlisted. They advised that there should be
further exploration of the tests and at risk groups
through the qualitative interviews in the next phase of
the intervention development [15,16].
There is debate about what initial percentage agree-
ment demonstrates consensus. We selected those with a
median of 5.5 and above on our 0-10 scale and this is
supported in other studies where consensus or agree-
ment can range from a starting percentage of 51% to
70% [14,26,27].
It may be argued that using an advisory panel as well
as doing a Delphi survey made our study complicated
and that the Delphi study was in some ways over ruled
by the panel. However, we believe that both approaches
enhanced our work in that we gained both a clinical per-
spective, evidence based perspective as well as a practical
approach to the next stage of the study.
The findings from this study are consistent with the
World Glaucoma Association (WGA) consensus guide-
lines on glaucoma screening [28]. The guidelines high-
light that the best single test or group of tests for OAG
screening are not yet determined and it was noted that
the tests that are available and effective for case- finding
are not necessarily the same as those for population
screening. The WGA consensus guidelines note that al-
though the best evidence to date suggests screening of
high risk subgroups is more cost-effective it also sug-
gests that population-based screening studies are
required to determine optimal screening strategies andtheir cost-effectiveness [28]. The WGA guidelines
process did not use formal consensus methodology and
the evidence to underpin the guidance was not identified
or synthesized systematically.Conclusions
This study has used an established method for the sys-
tematic use of expert opinion, informed by prior Health
Technology Assessment reviews [4,6,7]. It informs the
choice, from the many potential screening test interven-
tions, of those interventions most likely to be feasible for
population screening for glaucoma. The next step of this
research is to explore the feasibility and acceptability of
these interventions to both service providers and users
and to evaluate their potential cost-effectiveness. This
phased approach develops the methodology for complex
interventions in the context of a potential glaucoma
screening trial.Additional files
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